Vimarsana
Biggest News Aggregation in the World

Page 7 - Transfer Hub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transfer Hub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transfer Hub Today - Breaking & Trending Today

How drug companies are sidestepping the WHO's technology transfer hub in Africa - Vimarsana News

How drug companies are sidestepping the WHO's technology transfer hub in Africa

The decisions by BioNTech and Moderna to invest in other vaccine sites in African and not assist the mRNA Technology Transfer Hub in South Africa will prolong the social and economic costs of the pandemic, says David Richard Walwyn.

Source: ewn.co.za
How drug companies are sidestepping the WHO's technology transfer hub in Africa - Vimarsana News

How drug companies are sidestepping the WHO's technology transfer hub in Africa

Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture Covid-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) vaccines. Due to their higher efficacy, mRNA vaccines are the preferred option in developed countries. They account for 92% of all vaccinations to date in the US and European Union. Moderna’s decision to continue making the vaccine itself, though on the Kenyan site, is a signal that the company (at least for the moment) is not considering licensing its technology to a t...

How drug companies are sidestepping the WHO's technology transfer hub in Africa - Vimarsana News

How drug companies are sidestepping the WHO's technology transfer hub in Africa

The actions of BioNTech and Moderna will prolong the social and economic costs of the pandemic

How drug companies are sidestepping the WHO's technology transfer hub in Africa - Vimarsana News

How drug companies are sidestepping the WHO's technology transfer hub in Africa

Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.

In-depth: How a Cape Town company made an mRNA vaccine and what happens next - Vimarsana News

In-depth: How a Cape Town company made an mRNA vaccine and what happens next

Catherine Tomlinson takes an in-depth look at how Afrigen managed to reach this point and what further challenges have to be overcome before mRNA vaccines can be produced at scale in South Africa.

Source: news24.com